This paper outlines some of the evidence that tobacco smoking is maintained by addiction to nicotine. Smokers often perceive that tobacco helps them cope with stress and aids their mental alertness. Nicotine withdrawal symptoms are one important factor pre venting many smokers from quitting (only about 3% succeed with each unaided quit attempt). A number of policies are suggested to reduce the health consequences of smoking more quickly than at present. These include
(a) banning all tobacco advertising and prosecuting retailers who sell illegally to children, in order to reduce the number of young people becoming addicted,
(b) increasing the real price of tobacco in order to encourage more people to try to stop smoking,
(c) providing specialist smokers' clinics in every large general hospital in order to assist highly motivated but addicted smokers to quit and
(d) increasing the rate at which tobacco manufacturers must reduce permissible tar and carbon monoxide yields, such that in 20 years time only nicotine delivery products which are free of tar and carbon monoxide will be allowed.
Get full access to this article
View all access options for this article.
References
1.
Anthonisen and the Lung Health Study Research Group (1994). Effects of smoking intervention and the use of an inhaled anticholinergic bronchodilator on the rate of decline of FEVI. JAMA: 272, 1497-1505
2.
Benowitz N.L. and Henningfield J.E. (1994). Establishing a nicotine threshold for addiction: the implications for tobacco regulation. N Engl J Med; 331, 123-125
3.
Benowitz N.L. and Jacob P. (1985). Nicotine renal excretion rate influences nicotine intake during cigarette smoking. J Pharmacol Exp Ther ; 234, 153-155
4.
Benowitz N.L., Jacob P., Kozlowski L.T. and Yu L. (1986). Influence of smoking fewer cigarettes on exposure to tar, nicotine, and carbon monoxide. N Engl J Med:315, 1310-1313
5.
Benowitz N.L., Porchet H. and Peyton J. (1990). Pharmacokinetics, metabolism, and pharmacodynamics of nicotine. In: Nicotine Psychopharmacology: Molecular. Cellular and Behavioural Aspects; 374-418. (Wonnacott S, Russell M A H and Stolerman I P, eds). Oxford: Oxford University Press
6.
Cohen S., Lichtenstein E., Prochaska J.O. et al (1989). Debunking myths about self-quitting: evidence from 10 prospective studies of persons who attempt to quit smoking by themselves. American Psychologist : 11, 1355-1365
7.
Cox B.D. (1987). The health and lifestyle survey. London: Health Promotion Research Trust
8.
Department Of Health (1994). Smoke-free for health: an action plan to achieve the Health of the Nation Targets on smoking. UK Department of Health. London
9.
Foulds J. (1993). Does nicotine replacement therapy work?Addiction; 88, 1473-1478
10.
Foulds J., McSorley K., Sneddon J., Feyerabend C., Jarvis M.J. and Russell M A H (1994). Effect of subcutaneous nicotine injections on EEG alpha frequency in non-smokers: a placebo-controlled pilot study. Psychopharmacology; 115, 163-166
11.
Foulds J., Stapleton J., Feyerabend C., Vesey C., Jarvis M.J. and Russell M A H (1992). Effect of transdermal nicotine patches on cigarette smoking: a double blind crossover study. Psychopharmacology; 106, 421-427
12.
Fuxe K., Andersson K., Harfstrand A., Eneroth P., Perez DELa Mora M. and Agnati L.F. (1990). Effects of nicotine on synaptic transmission in the brain. In: Nicotine Psychopharmacology: Molecular. Cellular and Behavioural Aspects, 374-418. (Wonnacott S, Russell M A H and Stolerman I P, eds). Oxford: Oxford University Press
13.
Gilbert D.G. and Wesler R. (1989). Emotion, anxiety and smoking. In: Smoking and Human Behaviour. 171-195. (Ney T and Gale A, eds). London: John Wiley and Sons
14.
Hastings G.B., Ryan H., Teer P. and Mackintosh A.M. (1994). Cigarette advertising and children's smoking: why Reg was withdrawn. BMJ: 309, 933-937
15.
Henningfield J.E., London E.D. and Benowitz N.L. (1990). Arterio-venous differences in plasma concentrations of nicotine after cigarette smoking. JAMA;263, 2049-2050
16.
Herning R.I., Jones R.T. and Bachman J. (1983). EEG changes during tobacco withdrawal. Psychophysiology; 20, 507-512
17.
Hughes J.R. (1991). Distinguishing withdrawal relief and direct effects of smoking. Psychopharmacology: 104, 409-410
18.
Hughes J.R., Gulliver S.B., Fenwick J.W., Valliere W.A., Cruser K., Pepper S., Shea P., Solomon L.J. and Flynn B.S. (1992). Smoking cessation among self-quitters. Health Psychol; 11, 331-334
19.
Jackson P.H., Stapleton J.A., Russell M A H and Merriman R.J. (1986). Predictors of outcome in a General Practitioner intervention against smoking. Prev Med : 15, 244-253
20.
Jason LA, Ji P.Y., Anes M.D. and Birkhead S.H. (1991). Active enforcement of cigarette control laws in the prevention of cigarette sales to minors. JAMA : 266, 3159-3161
21.
Johnston L.M. (1942). Tobacco smoking and nicotine. Lancet; ii, 742
Nutbeam D., Macaskill P., Smith C., Simpson J.M. and Catford J. (1993) Evaluation of two school smoking education programmes under normal classroom conditions. BMJ ; 306, 102-107
25.
Perkins K.A., Grobe J.E., Fonte C., Goettler J., Caggiula A.R., Reynolds W.A., Stiller R.L., Scierka A. and Jacob R.G. (1994). Chronic and acute tolerance to the subjective, behavioural and cardiovascular effects of nicotine in humans. J Pharmacol Exp Ther: 270, 628-638
26.
Peto R., Lopez A.D., Boreham J., Thun M. and Clark H. (1994). Mortality from smoking in developed countries 1950-2000. Oxford: Oxford University Press
27.
Russell M A H (1987). Nicotine intake and its regulation by smokers . In: Tobacco Smoking and Nicotine; 25-50. (Martin W R, Van Loon G R, Iwamoto E T and Davis L, eds) London: Plenum Publishing Corporation
28.
Russell M A H (1990). Nicotine intake and its control over smoking . In: Nicotine Psychopharmacology: Molecular, Cellular and Behavioural Aspects. 374-418. (Wonnacott S, Russell M A H and Stolerman I P, eds). Oxford : Oxford University Press
29.
Russell M A H, Stapleton J.A., Feyerabend C., Wiseman S.M., Gustavsson G., Sawe U. and Connor P. (1993). Targeting heavy smokers in general practice: randomised controlled trial of transdermal nicotine patches. BMJ : 306, 1308-1312
30.
Russell M A H, Wilson C., Patel U.A., Feyerabend C. and Cole P.V. (1975). Plasma nicotine levels after smoking cigarettes with high, medium and low nicotine yields. BMJ ; 2, 414-416
31.
Schachter S., Kozlowski L.T. and Silverstein B. (1977). Effect of urinary pH on cigarette smoking. J Exp Psychol (Gen): 106, 13-19
32.
Silagy C., Mant D., Fowler G. and Lodge M. (1994). Meta-analysis on the efficacy of nicotine replacement therapies in smoking cessation. Lancet ; 343, 139-142
33.
Smee C. ( 1992). Effect of tobacco advertising on tobacco consumption. A discussion document reviewing the evidence. London: Economic and Operational Research Division, Department of Health
34.
Snyder F.R., Davis F.C. and Henningfield J.E. (1989). The tobacco withdrawal syndrome: performance decrements assessed on a computerised test battery. Drug Alc Dep; 23, 259-266
35.
Stolerman I.P., Fink R. and Jarvik M.E. (1973). Influencing cigarette smoking with nicotine antagonists . Psychopharma-cologia: 30, 247-259
36.
Sutherland G., Stapleton J., Russell M A H, Jarvis M.J., Hajek P., Belcher M. and Feyerabend C. (1992). Randomised controlled trial of nasal nicotine spray in smoking cessation. Lancet; 340, 324-329
37.
Townsend J., Roderick P. and Cooper J. (1994). Cigarette smoking by socioeconomic group, sex, and age: effects of price, income, and health publicity. BMJ; 309, 923-927
38.
Us Department Of Health And Human Services ( 1988). The health consequences of smoking: Nicotine addiction . Washington DC: US Government Printing Office
39.
Warburton D.M. and Arnall C. (1994). Improvements in performance without nicotine withdrawal. Psychopharmacology; 115, 539-542
